Carbon monoxide is a common domestic and industrial poison which may be lethal. Survivors can develop permanent neuropsychiatric disability. The mechanisms of toxicity are poorly understood and the traditional criteria used to determine the severity of the poisoning have low predictability. Oxygen is the recommended antidote to carbon monoxide, but it appears that oxygen under hyperbaric conditions repeated either daily or as indicated by the patient's condition may be required to provide an effective dose. A reliable marker of the severity of carbon monoxide poisoning is urgently needed so that trials of alternative regimens can proceed.
odourless, tasteless and non-irritant gas produced by incomplete organic combustion. Although it has been removed from most domestic gases it is still the most common fatal poison in many countries. I In western societies, motor vehicles (LPG and liquid fuels) are involved in most poisonings, and many of these are suicide attempts.
Survivors may be left with neuropsychiatric deficits.
2 Surprisingly, the toxic mechanisms of this important poison are not understood and consequently the optimal treatment has not been established. Some recent reviews of CO poisoning have only analysed selected clinical reports and consequently are misleading. This review is presented to outline the difficulties a physician faces in managing a patient with CO poisoning.
The toxic mechanisms and pathophysiology of carbon monoxide
It is still widely believed that CO is toxic only because of its binding to haemoglobin (Hb) and the consequent reduction in tissue oxygenation. 3 However, it has been known for sixty years that CO has a significant toxicity unrelated to tissue oxygen (0 2 ) delivery.4 Also, carboxyhaemoglobin (COHb) itself is not toxic,5,6 patient outcome does not correlate well with COHb levels measured in hospitaJ,1·11 titration of treatment against the COHb concentration is often unsuccessfuls,1O and *B.Sc., F.A.C.O.M., Ph.D. tF.F.A.R.A.C.S., Ph.D.
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Accepted for publication April 26, 1991 body stores of CO remain elevated after COHb levels have returned to normal. 12 CO will also bind to and inhibit the other haemoproteins (myoglobin, reduced cytochrome C, reduced cytochromes of the P 450 type and tryptophan dioxygenase) .13,14 Although inactivation of cytochrome C could explain its toxicity, carbon monoxide's affinity for the mitochondrial enzymes is very low compared with that of O 2 . 13 Indeed, severe intracellular hypoxia is probably a prerequisite for significant CO-cytochrome C binding l3 and patients who develop neuropsychiatric deficits after CO poisoning are often not acutely acidotic. I 5 Because CO is a small molecule and has a large dipole moment, as a result of the uneven sharing of electrons between the carbon and oxygen atoms, it readily and tenaciously adsorbs to many solid surfaces (Hills BA, personal communication, 1987). In many circumstances it will compete successfully for adsorption sites with other reagents. Thus it is possible that reduced rates of reaction may underlie its clinical toxicity.
CO causes lipid peroxidation, a process that continues even after removal of the tissue from the CO source, 16 and dilates blood vessels in the absence of Hb. 17 The latter may be due to a direct inhibition of calcium uptake. In vitro, CO has similar effects to nitric oxide on vascular smooth muscle. IS The relative contributions of these various mechanisms to clinical poisoning are not known.
The pathological changes in severely poisoned patients have been shown by computerised tomography, nuclear magnetic resonance imaging and post mortem examination to include necrosis of the globus pallidus, cerebral cortex, hippocampus, cerebellum and substantia nigra. [19] [20] [21] [22] It has been argued that myocardial depression occurs due to CO-myoglobin binding,19 and that the consequent hypotension will also contribute to the evolving brain damage. However, the pathological changes seen in severe CO poisoning are not identical to those of hypoxic brain injury, and the relevance of these findings to mild CO poisonings is uncertain.
Concurrent poisoning with CO and cyanide is common in both industrial and domestic fires; hydrogen cyanide gas arises from the burning of plastics and polyacrylic fibres. 3 While CO binds to ferrous iron (Fe 2 +), cyanide binds to ferric iron (Fe3+) and hence prevents the reoxidation of reduced cytochrome a3' In a combined exposure the toxicities of CO and cyanide are synergistic. 23 This synergy can not be explained by altered blood CO or cyanide concentrations.
The clinical presentation and course of carbon monoxide poisoning
Neurologic dysfunction, and in particular reduced consciousness, dominate the clinical presentation of CO poisoning. I ,2,8,9,24-28 Cardiovascular manifestations are less common, and usually comprise asymptomatic ST segment changes on an electrocardiograph. Other infrequent presentations include cardiac arrhythmias, hypotension, pulmonary oedema and cardiorespiratory arrest. The often cited cherry-red colouration is rare, late, and is much less common than cyanosis.
Unless the patient dies, removal from the CO source is usually followed by recovery and this can be accelerated by breathing O 2 . 2 ,26 Some recoveries are incomplete,28 and others continue after the patient is discharged from hospital (late recoveries)Y Patients who recover can also subsequently relapse or deteriorate (late deteriorations).2,8.26,29-31 The mechanism of these late deteriorations is unknown; they can become evident as early as the day after admission, have a peak occurrence within a week of the poisoning, and, rarely, occur as late as six weeks after the poisoning. 8 ,24,31 They may be a variation of the delayed encephalopathy seen after other ischaemic brain insults.32 Alternatively, they may be related to lipid peroxidation which occurs after tissues are removed from a CO source. 16 Lipid peroxidation, and its demonstrated inhibition by O 2 ,16,33 may also explain why hyperbaric O 2 has been shown to be an effective treatment of these deteriorations when they do occur. 8 
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This variable natural history was clearly seen by Smith and Brandon 2 ,26 in their series of 206 patients poisoned with CO. Only the more seriously affected patients were given O 2 to breathe. Although 33% died or were dead on arrival at hospital, only 2.2% of the survivors had obvious neuropsychiatric deficits at the time of their hospital discharge. 26 When these patients were subsequently reviewed three years later, 10.8% had gross neuropsychiatric deficits, 28.4% had an obvious personality deterioration and 36.5% had some loss of memory functions. 2 These late recoveries and deteriorations demonstrate why morbidities quoted at discharge will be misleading and why comparisons of clinical series must be restricted to those with measurements oflong-term outcome.
The assessment of severity of carbon monoxide poisoning
To date, attempts to define severe CO poisoning have been unsuccessful. Many of these have been based on COHb levels. I ,3,34 However, patient outcome correlates poorly with the COHb levels measured in hospital. 7-11 Indeed, survivors cannot be distinguished from nonsurvivors on this basis. 9 This is probably due to the significant CO toxicity that is not related to Hb,4 the alternative body depots for CO other than Hb l2 and the rapid dissociation of COHb. The half-life of COHb decreases from between 320 and 480 minutes in a subject breathing room air, to between 60 and 80 minutes under normobaric O 2 (100% O 2 at atmospheric pressure), and to between 8 and 23 minutes under various conditions of hyperbaric O 2 . 7 ,13,35 Also, clinical assessment 8 ,29 and arterial blood gas tension measurements l5 at the time of hospital admission do not identify all the CO-poisoned patients who will suffer a late deterioration. The utility of computerised tomographic brain scans 22 and psychometric testing 8 ,36 is yet to be established. While some authors report that a history of unconsciousness indicates severe CO poisoning,37 this is not a universal finding.
Myers et a/. 8 in Baltimore reported a series in which 213 patients were divided into 'mild' and 'severe' groups on the basis of neurological and psychometric examination, and COHb levels. The 82 'mild' poisonings were given normobaric O 2 , and 10 of these (12.2%) developed clinically significant sequelae. The 131 'severe' poisonings were treated with hyperbaric O 2 and with the exception of one patient who was re-exposed to CO, no sequelae were seen.
It thus appears that the traditional patient selection criteria for treatment have little validity, and that there is an urgent need for a reliable marker of severe CO poisoning. Without such a marker, treatment and follow-up should be offered to all patients with a convincing history of both exposure to CO and of intoxication (i.e. focal neurological deficits, impaired consciousness, myocardial ischaemia, at the time of the exposure), regardless of their condition on arrival at hospital. In this context, an increased COHb concentration may be useful in confirming that the patient has been exposed to CO.
The treatment of carbon monoxide poisoning
An increased inspired O 2 tension is the recommended treatment of CO poisoning as O 2 is a competitive antagonist to CO for haemoprotein binding,13 increased O 2 in solution in the plasma will offset the reduced tissue O 2 delivery secondary to COHb formation 3 and O 2 will inhibit lipid peroxidation secondary to CO. 1 6 Only one prospective randomised controlled clinical study of O 2 in CO poisoning has been reported,37 but this study used O 2 doses which have been shown to be ineffective. 8, 11, 25, 30, 38, 39 Hence, the optimal O 2 therapy (Pi02, duration and frequency) for CO poisoning is unknown.
Concurrent poisoning with CO and cyanide is common. 3 O 2 therapy has also been proposed as an antidote to cyanide. However, in cyanide poisoning, O 2 delivery to the tissues is normal. O 2 will not antagonise cyanide binding to the cytochromes as cyanide binds to ferric (Fe 3 +) and not ferrous (Fe 2 +) iron and when O 2 is administered the cytochrome oxidase equilibrium will predictably shift to the oxidised form. In addition, an 02-dependent increase in cyanide metabolism can not be demonstrated. 4o Any role for O 2 as an antidote to cyanide would therefore be surprising; available animal data are inconclusive,41-44 and human data are limited to individual case reports. 45 ,46 Importantly however, there is no suggestion from these data that O 2 worsens the outcome after cyanide poisoning, and it is clear that O 2 is highly effective in reducing the toxicity of the conventional cyanide antidotes, amyl and sodium nitrite. 42 ,44 This is not surprising given that these nitrites are profound vasodilators and by producing methaemoglobin will reduce tissue O 2 delivery.3 Thus O 2 should still be given to patients poisoned with CO, even if concurrent cyanide poisoning is suspected.
Given the uncertainty about the ideal O 2 dose for CO poisoning, some physicians have titrated treatment against the COHb level, without success. In 82 patients poisoned with CO, normobaric O 2 was given until the COHb was maintained for at least one hour at less than 5%8: ten of these patients developed an encephalopathy. In another 31 patients poisoned with CO, hyperbaric O 2 at 3 AT A was maintained until the COHb fell below 10%10: six of these patients suffered sequelae.
In thirteen published series of 3441 poisoned patients, both O 2 dose and long-term outcome (at least one month morbidity) can be determined (Table 1) .
In 1011 patients treated with normobaric O 2 ,8,11,25,29,30,37-39 a mortality rate of 30% was not, variously, prevented by prolonged hyperventilation with O 2 , hypothermia, moderate dehydration, steroids, barbiturate sedation or neuromuscular blockade. 38 The long-term morbidity in survivors was reported to be between 12 and 66% and, despite an initial recovery, a late deterioration in neurological function was seen in 12.2% of patients in one series 8 and in 11.8% of patients in another. 25 A single hyperbaric O 2 treatment has been associated with similarly poor outcomes; a 32.4% long-term sequelae rate in 173 patients who did not have an impaired level of consciousness,37 a 45.5% long-term sequelae rate in 145 patients who had impaired consciousness,37 and between 19 and 48% morbidity in other series in which patients were not divided into mild and serious categories. 10,1 I Two groups of French authors have reviewed their 'success' with a fixed regimen of two hyperbaric O 2 treatments (2 A TA for two hours each) given to patients during the first day of their admission to hospital. In the first series of 273 patients, 15.4% died, and 7.5% of the survivors were left with major long-term sequelae and another 11.7% with minor sequelae. 3o Of these 53 patients with residual deficits, 20 had experienced an initial recovery during the O 2 treatment only to deteriorate subsequently. In the other series, 47.5% of 142 patients who had lost consciousness were left with long-term sequelae. 37
It is even possible that normobaric O 2 and these limited hyperbaric O 2 regimens do not significantly influence the natural history of CO poisoning. 28 Raphael et at. 37 recently cited a series reported by Blettery and colleagues as showing a 1.1 % neurological morbidity in 90 patients poisoned with CO and treated with normobaric O 2 , However, this was in fact the mortality in this series and the long-term morbidity was not measured. 24 In contrast to these poor outcomes, in 1594 patients poisoned with CO and given hyperbaric O 2 both on admission and then either repeated daily or as frequently as required by the patient's condition, 8, 9, 22, 27, 29, 39, 47 mortality varied between 0 and 9.6% and was essentially seen only in those who had a cardiac arrest before arrival at hospital. The long-term morbidity varied between 0 and 4.4%, and none of these patients suffered a late deterioration in brain function. The exception to these good outcomes was in a group of eleven patients who had been unconscious for at least six hours and had pronounced computerised tomographic brain scan changes prior to any hyperbaric O 2 . 22 It is clear then that even allowing for the inherent difficulties in comparing clinical series of this nature, administration of hyperbaric O 2 (at either 2 or 3 ATA for one to two hours) on admission to hospital, and repeated either daily or as made necessary by the patient's condition, is the only adequate treatment of CO poisoning yet demonstrated. This is particularly important with respect to preventing the late deteriorations typical of this poison. Because the permanent patient morbidity caused by hyperbaric O 2 itself in this context is very low,3o the major problem in the treatment of CO poisoning is not treatment regimen selection, but patient selection.
Nevertheless, the controversy about the role and dose of O 2 in CO poisoning can only be resolved by prospective randomised controlled clinical studies of a wide range of O 2 therapies. Recently proposed clinical research testing repeated normobaric O 2 against repeated hyperbaric O 2 has not been successful in gaining ethical consent, and these important studies will probably have to be postponed until the mechanism of CO toxicity is better understood and/or a marker of severity of poisoning has been identified. The prevalence of CO poisoning and the associated mortality and morbidity underlie the urgent need for research in this area.
